Introduction
In the early 2000s, India was believed to have the highest burden of HIV infections in the world, 1 with prevalence rapidly increasing. 2, 3 Therefore, in 2003, the Bill & Melinda Gates Foundation established Avahan, the India AIDS initiative, to target the high-risk groups that the evidence suggested were driving the HIV epidemic in India. 4, 5 By reducing the prevalence in these groups, they hoped to interrupt the downstream chain of transmission to the general population. Avahan established a largescale, targeted HIV preventive intervention, providing services to an estimated 300 000 female sex workers and high-risk men who have sex with men (ie, those who have large numbers of partners, often sell sex, or practice receptive anal sex). 6 Through state-level providers and local non-governmental organisations (NGOs), Avahan worked in 69 districts in four states of South India (Andhra Pradesh, Karnataka, Maharashtra, and Tamil Nadu). Programme components outside the scope of this assess ment were active in other regions, reaching truck drivers and injecting drug users. The standard Avahan care package consisted of peer education and outreach; distribution and social marketing of condoms; treatment of sexually transmitted infections (STIs) for female sex workers and high-risk men who have sex with men; and structural interventions and community mobilisation components to address distal determinants of HIV risk such as violence and stigma. 6 Antiretroviral therapy was not off ered as part of this package, but HIV counselling and testing were strongly promoted, with active referral to government antiretroviral therapy centres for individuals who tested positive. Overall, coverage of antiretroviral therapy by government and private clinics reached only Rollout of Avahan programme activities began in January, 2004, reaching almost all districts by mid-2005, 10 and with rapid scale-up within each district. [11] [12] [13] By December, 2008, more than 75% of the estimated target populations of female sex workers (total population 217 000) and high-risk men who have sex with men (total population 80 000) were being contacted monthly. 10 In 28 districts Avahan was the fi rst and only intervention; 10 in the remaining 41 districts it worked alongside or took over from existing NGO interventions. From an assessment standpoint, this rapid rollout, the presence of other interventions, and ethical considerations mitigated against the use of community-based randomised controlled trials or a stepped-wedge study design. [14] [15] [16] This independent assessment (the CHARME-India project) was planned as an integral part of Avahan. 17 In place of community-based randomised controlled trials, we used mathematical modelling with detailed HIV and STI prevalence and behavioural data to obtain plausible evidence for the eff ectiveness of the intervention. 17 We fi rst investigated the eff ect of Avahan in the high-risk groups targeted by the intervention, and then traced the eff ect on their long-term partners in the general population, refl ecting the intended causal pathway of the intervention. We believe that this approach improves on a previous analysis of the population-level eff ect of Avahan, 18 which did not take into account the high-risk groups on which programme activities focused, but instead used a static approach to model eff ectiveness through district-level diff erences in HIV prevalence trends in women attending antenatal care clinics. That analysis was also limited by the fact that antenatal clinic data can be subject to transient biases, [19] [20] [21] leading to estimated HIV time trends that are unrepresentative of the general population prevalence. 22 By means of a Bayesian inference method, 23 we aimed to use hypothesis testing to examine whether observed prevalence trends in high-risk groups were suggestive of evidence for condom use increasing faster during Avahan than beforehand, and to estimate, using the mathematical model, the number and proportion of HIV infections averted by Avahan because of these increases in condom use (ranked by the strength of evidence from the hypothesis testing).
Methods

Data sources
The primary data collected as part of the Avahan assessment were the serial cross-sectional integrated behavioural and biological assessment (IBBA) surveys done among female sex workers, their clients, and men who have sex with men in 24 districts, referred to as IBBA districts. 24, 25 IBBA districts have about 38% of the female sex workers and 45% of the high-risk men who have sex with men across the 69 Avahan districts in South India. At least two rounds of IBBAs for female sex workers were done in each district, with a median of 37 months between rounds one and two (appendix).
We used IBBA data to obtain behavioural parameter estimates, and HIV and STI prevalence data for model fi tting. Additional special behavioural surveys were used to refi ne the structure of sexual behaviours in the mathematical model (appendix). We also used general population biobehavioural surveys from four IBBA districts, 22, 26, 27 with concurrent anonymous polling-booth behavioural surveys for examining sensitive behaviours, 28 to derive ranges for behavioural parameters of the general population.
Data collection for the IBBAs started 7-24 months after intervention activities began, so no true baseline surveys or pre-Avahan data for condom use exist. Therefore we estimated time trends for consistent condom use before Avahan from IBBA data, as reported previously. 29 After the start of Avahan, consistent condom use was assumed to increase up to the proportions reported in each IBBA survey, because of scale-up in each district, and to remain constant thereafter at the proportion reported in the most recent IBBA. We used these estimated historical trends in consistent condom use to defi ne the intervention condom hypothesis (ie, that consistent condom use increased more rapidly during Avahan than before hand), used at the hypothesis-testing stage and to estimate eff ectiveness. Programmatic outputs, such as number of STI clinic visits, were monitored monthly by NGOs from January, 2005, 10 until April, 2011, and were used to estimate syphilis treatment rates (appendix).
Finally, Avahan grantees did mapping exercises to estimate the population sizes of female sex workers and high-risk men who have sex with men. We used the most recent available size estimates for each district. We estimated client population sizes indirectly using a multiplier method that involved balancing the overall frequency of com mercial sex reported by female sex workers and their clients (appendix). 30, 31 Estimates were validated with data from general population polling-booth surveys 28 where available. Table 1 summarises the main parameters, a full list of which is reported in the appendix.
Transmission model
A previously reported model of HIV transmission 23 was extended to simulate the HIV epidemic in high-risk groups and between high-risk individuals and their partners in IBBA districts. The model has two components: a deterministic transmission-dynamics model of HIV, herpes simplex virus 2 (HSV2), and syphilis in high-risk groups (high-risk model component); and a linked, individual-based model of HIV and HSV2 transmission to the long-term, non-commercial partners of high-risk men and former high-risk individuals (general-population model component). The individual-based component was chosen to better represent long-term stable relationships.
Both model components incorporated increased transmissibility during acute and late-stage HIV infection and the cofactor eff ects of HSV2 on HIV infectivity and susceptibility. The high-risk model component also included the cofactor eff ect of syphilis on HIV susceptibility. The appendix provides a full description of the model.
Fitting and hypothesis testing
The two hypotheses we examined were the intervention condom hypothesis, which generally suggests that consistent condom use increased more rapidly during Avahan than beforehand; and the control condom hypothesis, which was defi ned as consistent condom use increasing at the same rate during Avahan as beforehand-ie, that Avahan had no additional eff ect on consistent condom use beyond what was already happening. A Bayesian modelfi tting algorithm 23, 32 was used to test whether each district's observed HIV prevalence trends in high-risk groups were more consistent with one hypothesis or the other. For both hypotheses, consistent condom use remained stable after the fi nal IBBA. The appendix includes the consistent condom use trends for each district.
We defi ned ranges for each model parameter for each district using data from IBBA and other surveys, as well as the scientifi c literature for biological parameters (table 1, appendix). We then uniformly sampled these ranges multiple times using Latin hypercube sampling, 33 as described in the appendix. For each parameter set thus created, the model was run twice for both the intervention and control condom hypotheses. Only simulations within the 95% CI of prevalence data for HIV, HSV2, and syphilis from the round one IBBA for diff erent high-risk groups, and within the 95% CI of the adjusted trend in HIV prevalence among female sex workers between round one and later IBBA rounds, were retained as model fi ts to form the posterior parameter set for that district for the given condom use hypothesis. For hypothesis testing, the Bayes factor, described fully in the appendix and approximated by the ratio of the number of fi ts to each hypothesis, was used to determine whether there was weak (Bayes factor ≤2), moderate (>2 to 5) or strong (>5) evidence 34 
Eff ectiveness analysis
For each modelled district, we obtained between 30 and 266 fi tted runs for the intervention condom hypothesis, capturing the uncertainty from biological and behavioural parameters in the model projections. These runs generated district-level estimates of HIV prevalence and incidence over time, as well as the number of HIV infections among high-risk individuals and linked infections to long-term partners of present and former high-risk individuals. To estimate eff ectiveness in each district, we produced a matched counterfactual for each model fi t of the intervention condom hypothesis, using the same posterior parameter set, but instead assuming that consistent condom use increased in accordance with the control condom hypothesis and that syphilis treatment remained at the assumed background rate. We calculated HIV infections averted for each model fi t relative to this matched counterfactual, and combined these fi ts to give a 95% credibility interval (CrI) for the number and proportion of infections averted in each district using likelihood weights, 23 as described in the appendix. Eff ectiveness was calculated over 4 and 10 years because these time periods corresponded to the fi rst phase of the Avahan programme (2004-07 or 2005-08 dependent on the district, during which time it reached scale 10 ) and entirety of the programme (2004-13), respectively. The programme has now largely been handed over to the Indian Government.
We estimated infections averted among female sex workers; clients of female sex workers; men who have sex with men; and long-term, non-commercial partners of clients and men who have sex with men. We derived fi ve alternative overall eff ectiveness estimates across all Avahan districts with increasing uncertainty, representing the hypothesis-testing results and the fact that not all IBBA districts had done surveys among men who have sex with men and the general population. Table 2 and the appendix fully describe these estimates and the sources of uncertainty. The fi rst estimate included only IBBA districts in which the evidence for the intervention condom hypothesis was moderate to strong (ie, Bayes factor >2), and estimates of infections averted among men who have sex with men and the general population were included only for districts with data available for these populations. Eff ectiveness among men who have sex with men and the general population in districts with moderate to strong evidence were added successively to produce the subsequent estimates. For the fourth estimate, districts with weak evidence (Bayes factor ≤2) were included. Finally, because IBBAs were only done in about a third of all Avahan districts, we extrapolated our estimates to all non-IBBA districts. We used linear regression for the estimates of HIV infections averted in modelled IBBA districts to extrapolate to non-IBBA districts using data, such as the sizes of high-risk populations, available across all Avahan districts. This estimate produced the overall number of HIV infections averted over the fi rst 4 and all 10 years of Avahan in South India, but with the highest degree of uncertainty.
Role of the funding source
The sponsor of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had fi nal responsibility for the decision to submit for publication. (Salem and Thane) could not be analysed because they had no fi ts with either the intervention or the control condom hypothesis, due to confl icting trends in HIV prevalence data between diff erent risk groups. Seven of the remaining 22 districts had strong evidence (Bayes factor >5) and six had moderate evidence (Bayes factor >2 to 5) that consistent condom use by female sex workers increased during Avahan. Nine districts had weak evidence (Bayes factor ≤2). In districts with weak evidence, the overall diff erence in consistent condom use between the intervention and control condom hypotheses in 2010 was generally smaller (16%) than for districts with moderate or strong evidence (57%; p=0·01 [MannWhitney test of the medians]; fi gure 2). This result was partly caused by the estimated baseline consistent condom use being higher (48%) in the districts with weak evidence than in the districts with moderate to strong evidence (12%). In four of the fi ve modelled districts in which Avahan was the fi rst intervention targeted at female sex workers, there was moderate or strong evidence for the intervention condom hypothesis; the exception was Yevatmal, where there was weak evidence, probably because its small IBBA sample size of female sex workers resulted in less informative estimates of condom use and HIV prevalence. with 67% of infections averted in Tamil Nadu, 49% in Andhra Pradesh, 36% in Karnataka, and 12% in Maharashtra. Over 10 years, eff ectiveness increased in all districts, with 57% (46-68%) of HIV infections averted across the modelled districts. The median number of HIV infections averted per district over the fi rst 4 years of the programme varied from 55 to more than 11 400. Six districts (four with moderate to strong evidence) contributed 63% of all infections averted, whereas the bottom six by contribution (fi ve with weak evidence) contributed only 6%. The total number of infections averted each year increased from 5000 in year 1 to 14 000 in year 2, 20 000 in year 3, and 23 800 in year 4.
Results
Over the fi rst 4 years, most HIV infections were averted among clients of female sex workers (51% of all infections averted), who formed the largest high-risk subpopulation, followed by the general population (19%), men who have sex with men (17%), and female sex workers (13%).
The district-specifi c estimates of eff ectiveness (fi gure 1) include infections averted in all population subgroups over the fi rst 4 years, even for districts without surveys of men who have sex with men and the general population, and the state-level and overall proportion of infections averted across all modelled districts. Table 2 shows the overall infections averted over 4 and 10 years, by increasing degree of uncertainty. In 18 IBBA districts, the modelled HIV prevalence among female sex workers fell during the fi rst 4 years under the intervention condom hypothesis by 11% to 52% dependent on the district, whereas it increased in four districts. Over 10 years, the projected median HIV prevalence fell in all districts to less than 14% among female sex workers, with only six districts having a median prevalence higher than 5% in this subpopulation (district-level prevalence-trend graphs are provided in the appendix). By comparison, under the control condom hypothesis HIV prevalence among female sex workers remained high, with seven districts having a prevalence higher than 20% after 10 years. Figure 2 shows the mean prevalence trends weighted by the size of the female sex worker population, grouped by strength of evidence. After the fi rst 4 years, the HIV incidence ratio between the intervention and matched counterfactual varied by between 0·08 and 0·92 (median 0·30) across modelled districts. For the intervention condom hypothesis, incidence in low-risk women fell during the fi rst 4 years in 19 districts, and after 10 years it had fallen by at least 70% in all districts, with larger reductions in incidence among female sex workers (appendix).
When only the subset of variables available across all Avahan districts was used, 62% of the variability in the number of HIV infections averted over the fi rst 4 years across IBBA districts, as measured by the R² value of the linear regression model, was accounted for by: the number of female sex workers in a district (positively associated, accounted for 24% of the variability);
whether Avahan was the main intervention provider for female sex workers in the fi rst year in that district (positively associated, 26%); and being a district in Maharashtra state (negatively associated, 12%). When this regression model, described in the appendix, was used to ex trapolate eff ectiveness estimates to all non-IBBA districts, the overall eff ectiveness of Avahan for all 69 districts was estimated to be 202 000 HIV infections averted over the fi rst 4 years (table 2), with 37% of infections averted in Andhra Pradesh, 30% in Karnataka, 8% in Maharashtra, and 25% in Tamil Nadu. Over 10 years, the number of infections averted increased to 606 000 across all districts. The two regression models for eff ectiveness over 4 and 10 years had the same independent variables, although they were built independently. Figure 3 shows how the number of infections averted varied geo graphically across all Avahan districts.
Discussion
Our results provide evidence for a large-scale increase in consistent condom use in high-risk groups since the start of the Avahan programme. Hypothesis-testing results show HIV prevalence trends are consistent with selfreported trends in consistent condom use by female sex workers and men who have sex with men in most districts, and that consistent condom use increased faster after the introduction of Avahan than before. Across the 22 modelled districts, the increases in consistent condom use that occurred during the fi rst 4 years of Avahan are estimated to have averted 42% of HIV infections, increasing to 57% over 10 years of the programme. This increase translates to 32 700-39 900 HIV infections averted over the fi rst 4 years in districts with moderate to strong evidence, or 62 800 across all modelled districts. Extrapolating to all 69 Avahan districts, we estimate that 202 000 HIV infections could have been averted over the fi rst 4 years of Avahan, increasing to 606 000 over 10 years. Both prevalence and incidence fell steeply in most districts, across all risk groups. For districts in which hypothesis testing did not show evidence of increased consistent condom use due to Avahan, this fi nding was probably because consistent condom use was generally quite high before Avahan (fi gure 2). Our attribution of eff ectiveness to Avahan is supported by other analyses. First, research by Bradley and colleagues 37 showed that condom distribution increased substantially in Karnataka after 2004, mainly because of Avahan, and suggested that the proportion of sex acts between female sex workers and their clients that were protected by a condom increased from 16-24% in 2004 to 81-89% in 2008. Second, statistical analysis of the reconstructed trend data for consistent condom use by female sex workers suggests that use increased faster after the beginning of Avahan than before in ten of 18 districts. 29 Finally, survey data suggest a dose-response relation between condom use between female sex workers and their clients and both time since fi rst contact with Avahan staff and the number of condom demonstrations seen. 38 The eff ectiveness of the intervention varied across districts, with the proportion of infections averted inversely related to pre-intervention consistent condom use (appendix). Understandably, for districts in which previous interventions had already led to high consistent condom use among high-risk groups before Avahan, only small, incremental eff ects could be achieved. Districts with low HIV prevalence and low consistent condom use at baseline, such as those in Tamil Nadu, had more infections averted than other districts, because the epidemic had more potential to grow.
Our results diff er in several important ways from those of the previous assessment of Avahan by Ng and colleagues, 18 which estimated that 100 200 HIV infections were averted by Avahan between 2004 and 2008. The earlier analysis compared HIV prevalence trends in women attending antenatal care clinics between Avahan and non-Avahan districts, with the assumption that intervention coverage was higher in Avahan districts. By contrast, our method compared the HIV epidemic trends in each district with what might have occurred in the absence of Avahan or any other intense, core-group intervention. Ng and colleagues' analysis probably underestimated the eff ectiveness of Avahan, since the Indian Government, through the National AIDS Control Organisation (NACO), implemented high-coverage, targeted interventions in many non-Avahan districts, 9 so non-Avahan districts have been exposed to interventions and cannot always be used as a valid counterfactual. For example, in Tamil Nadu, Ng and colleagues 18 reported no evidence for the eff ectiveness of Avahan, probably because of the long history of interventions in many of the non-Avahan districts in that state. By contrast, because Avahan was usually the fi rst and only intervention in the districts of Tamil Nadu in which it operated, our analysis estimated that 25% of HIV infections averted across all Avahan districts were in that state. Although Banandur and colleagues 39 used a similar method to Ng and colleagues, 18 their estimate of 87 000 HIV infections averted in Karnataka state between 2004 and 2008 is fairly close to our estimate of 60 300 over 4 years (data not shown).
The two approaches to the assessment of Avahan diff er in other ways. The previous analyses took into account only the eventual eff ect on the general population, without investigating the causal pathway through which the intervention achieved its eff ects. 16 By contrast, our analysis fi rst assessed eff ectiveness in the high-risk groups that were the focus of the Avahan programme, and then projected how this eff ect propagated to the general population, thereby taking into account the targeted nature of the intervention. It thus addresses some of the issues related to causation (panel).
Assessment of the eff ectiveness of HIV preventive interventions is crucial for determining which strategies should be prioritised. 46 This study sought to determine whether there is evidence that Avahan reduced the transmission of HIV among high-risk groups and the general population. It represents the fi rst preplanned, integrated use of mathematical modelling and data collection for assessment of a real-life, large-scale HIV intervention programme, 17 and its success suggests that our assessment design could be a viable alternative to randomised controlled trials. 40, 43 The mathematical model used was developed specifi cally to assess Avahan, with a structure refl ecting important sources of heterogeneity in IBBA data. The model was refi ned in consultation with epidemiologists and other expert non-modellers, and through exploratory modelling work. 4, 20, 23 The IBBA surveys used a detailed sampling frame derived from careful mapping of venues, and were designed for this assessment, providing previously unavailable information on HIV prevalence and risk behaviour of high-risk individuals across a large number of districts. Combined with systematically gathered programme data and size-mapping estimates, these survey data allowed for detailed and robust mathematical modelling projections of the eff ectiveness of Avahan in many diff erent settings, while accounting for uncertainty in estimates. We used an assessment design established 17 at the beginning of the study to minimise assessor biases. The eff ectiveness estimates were deliberately chosen to be conservative, with the assumption of the counterfactual scenario that condom use would have continued increasing at pre-Avahan rates in the absence of Avahan. Although the results for all 69 districts are based on an extrapolation from a linear regression model of IBBA districts, and therefore have more uncertainty, we present results with diff erent degrees of strength of evidence to quantify how uncertain our results are.
The approach used, of estimating eff ectiveness relative to a matched counterfactual, can be regarded as an attempt to reach the ideal estimation of relative risk, namely the comparison of a population to itself with the exposure removed. 47 However, it is not possible to know exactly what would have happened if Avahan had not intervened, and the absence of true empirical baseline data increases uncertainty. In some districts pre-existing interventions were present, which might have led to increased condom use in the absence of Avahan. Although our conservative counterfactual makes allowances for this, the absence of data from districts without any Avahan intervention makes the attribution of eff ectiveness to the programme with absolute certainty diffi cult. Additionally, limitations arise from the use of reconstructed condom trends based on selfreported condom use, and although we tried to allow for social desirability biases within the modelling, as well as cross-validating with non-survey methods, 37 it is not possible to know if this issue has been fully accounted for, although the use of Bayesian hypothesis testing provides further evidence that these trends are credible in these settings.
Eff ectiveness estimates are dependent on the sizes of the high-risk populations, and although mapping studies were specifi cally done in Avahan districts, the accurate mapping of hidden populations is challenging. 48 Migration from non-Avahan districts could reduce estimated eff ectiveness. Antiretroviral therapy could also be changing the epidemic, leading to higher HIV prevalence as survival improves. However, although long-term projections could be aff ected by increasing access to antiretroviral therapy, coverage remained low until after 2008, by which time IBBA surveys in most districts had been completed. 49 More over, modelling work suggests that the increase in HIV infections averted by antiretroviral therapy on top of the eff ect of Avahan is small (unpublished). Finally, although the IBBA districts comprise almost a third of all Avahan districts, they were not chosen randomly, so might not be representative. 50 However, these data limitations, such as the absence of baseline data, are neither intrinsic nor unique to our approach, and refl ect the realities of programme implementation and real-life assessment. 15 Our use of a simulated matched counterfactual for each district means that non-random district selection is less problematic than for approaches in which Avahan and nonAvahan districts are compared, such as in the study by Ng and colleagues, 18 or community-based randomised controlled trials, for which it might not be possible to fi nd comparable control districts, leading to imbalance. 51 A further issue for these alternative assessment designs, which rely on non-Avahan control districts, is the scalingup of targeted interventions by NACO in non-Avahan districts since 2007, 9 meaning that such analyses are eff ectively comparing Avahan with NACO interventions. Finally, although a step-wedge design can be useful for assessing intermediate outcomes, the present combined approach might be more suitable for assessing HIV interventions in populations, since changes in HIV prevalence and incidence might not be measurable for a long time. 51 In summary, using mathematical modelling to quantitatively synthesise HIV and STI prevalence data with key setting-specifi c behavioural indicators, we have shown strong and plausible evidence for a large
Panel: Research in context
Systematic review Avahan was a large-scale, complex HIV preventive intervention. Uniquely for such a large programme, assessment was based on a preplanned combination of serial cross-sectional data and mathematical modelling. 17 The use of mathematical modelling for assessment of health programmes was reviewed by Garnett and colleagues, 40 with the present assessment used as an example. Some eff ectiveness assessments of interventions targeted at female sex workers were done before Avahan, 41, 42 including one study 42 that examined the eff ect on the general population. In 2011, Ng and colleagues 18 reported an assessment of Avahan in which they compared trends in HIV prevalence in women attending antenatal care clinics between Avahan and non-Avahan districts within the same Indian states. They used level of intervention eff ort measured in terms of programme spending to take into account the fact that, in many districts, a mix of Avahan and non-Avahan interventions were targeting the same high-risk populations. The investigators estimated that from 2004 to 2008, Avahan had averted about 100 000 HIV cases. Their approach, however, did not take into account the causal pathway that could have led to a reduced HIV incidence. 16 Using a similar method, Banandur and colleagues 39 estimated that 87 000 HIV infections were averted by Avahan in Karnataka state alone over the same period.
Interpretation
Our study constitutes probably the most rigorous use of mathematical modelling for the assessment of a public health programme so far reported. We show that this approach is feasible and provides an alternative to community-based randomised controlled trials, which might not be the ideal approach to assess large, complex interventions. 43 In particular, a randomised trial would not have allowed for the context-specifi c, community-led response that was an integral part of Avahan. 44 Model projections of HIV prevalence were fi tted to multiple rounds of data from diff erent risk groups, and a Bayesian framework was used to assess the strength of evidence for eff ectiveness. Additionally, we explicitly modelled the causal pathway of the intervention. Our study also incorporated diff erent degrees of uncertainty dependent on the amount of data available for each district. Our results generally support those of Ng and colleagues, 18 showing that Avahan has prevented a large number of HIV cases in India. However, our estimate of 202 000 HIV cases averted over the fi rst 4 years of the programme is about double that estimated by Ng and colleagues. 18 This diff erence was probably due to the diff erences in the methods used. Whereas the previous assessment compared Avahan with other interventions, our assessment used a modelled counterfactual, in which exposure to Avahan was removed from the intervention population. Our assessment meets the criteria for plausibility in the Habicht and colleagues' framework, 45 and can be replicated for assessment of other large-scale, complex interventions.
intervention eff ect of Avahan, which increased over time, based on Habicht and colleagues' 45 scale for assessing the strength of evidence for eff ectiveness of public health interventions. This eff ect occurred through increased condom use, brought about by removing barriers to use via intervention components including distribution and social marketing of condoms, peer outreach, STI treatment, structural intervention, and community mobilisation. In an era focused on antiretroviral therapy as prevention, these results show that behaviour-focused, core-group-targeted HIV preventive interventions can be rapidly and successfully implemented at scale. The low coverage of such programmes in many regions of the world should be addressed, since with high coverage these programmes have the potential to substantially reduce concentrated HIV epidemics.
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